BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25187119)

  • 1. Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial.
    Patel DV; Bolland M; Nisa Z; Al-Abuwsi F; Singh M; Horne A; Reid IR; McGhee CN
    Osteoporos Int; 2015 Feb; 26(2):499-503. PubMed ID: 25187119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of acute anterior uveitis after intravenous zoledronate.
    Patel DV; Horne A; House M; Reid IR; McGhee CN
    Ophthalmology; 2013 Apr; 120(4):773-6. PubMed ID: 23290982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Re-challenge in Patients with a History of Acute Anterior Uveitis Following Intravenous Zoledronate.
    Patel DV; Horne A; Mihov B; Stewart A; Reid IR; McGhee CN
    Calcif Tissue Int; 2015 Jul; 97(1):58-61. PubMed ID: 26001948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer.
    Moore MM; Beith JM
    Med J Aust; 2008 Mar; 188(6):370-1. PubMed ID: 18341464
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis.
    Huang J; Meixner L; Fernandez S; McCutchan JA
    AIDS; 2009 Jan; 23(1):51-7. PubMed ID: 19050386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.
    Umunakwe OC; Herren D; Kim SJ; Kohanim S
    Digit J Ophthalmol; 2017; 23(4):18-21. PubMed ID: 29403337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronate-induced acute anterior uveitis: a three-case report and brief review of literature.
    Jin X; Shou Z; Shao Y; Bian P
    Arch Osteoporos; 2021 Jun; 16(1):104. PubMed ID: 34180015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral Acute Anterior Uveitis and Conjunctivitis following Intravenous Zoledronic Acid.
    Chatterjee S; Agrawal D
    J Assoc Physicians India; 2017 Jul; 65(7):110-111. PubMed ID: 28792180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serious ocular complications of zoledronate.
    Woo TC; Joseph DJ; Wilkinson R
    Clin Oncol (R Coll Radiol); 2006 Sep; 18(7):545-6. PubMed ID: 16969985
    [No Abstract]   [Full Text] [Related]  

  • 10. Zoledronic acid induced unilateral anterior uveitis.
    Gupta S; Onkar A; Vashisht T
    Indian J Ophthalmol; 2020 Sep; 68(9):2002-2003. PubMed ID: 32823458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fracture Prevention with Zoledronate in Older Women with Osteopenia.
    Reid IR; Horne AM; Mihov B; Stewart A; Garratt E; Wong S; Wiessing KR; Bolland MJ; Bastin S; Gamble GD
    N Engl J Med; 2018 Dec; 379(25):2407-2416. PubMed ID: 30575489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal women: secondary analysis of a randomized controlled trial.
    Reid IR; Horne AM; Mihov B; Stewart A; Garratt E; Wiessing KR; Bolland MJ; Bastin S; Gamble GD
    J Intern Med; 2019 Aug; 286(2):221-229. PubMed ID: 30887607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior uveitis complicating zoledronic acid infusion.
    Colucci A; Modorati G; Miserocchi E; Di Matteo F; Rama P
    Ocul Immunol Inflamm; 2009; 17(4):267-8. PubMed ID: 19657981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Bilateral Anterior Uveitis after a Single Intravenous Infusion of Zoledronic Acid in Metastatic Breast Cancer.
    Jun JH
    Korean J Ophthalmol; 2017 Aug; 31(4):368-369. PubMed ID: 28682020
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trial.
    Grey A; Bolland M; Wong S; Horne A; Gamble G; Reid IR
    J Clin Endocrinol Metab; 2012 Jan; 97(1):286-92. PubMed ID: 22072741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study.
    Liang BC; Shi ZY; Wang B; Wu P; Kong LC; Yao JL; Li CW; Shi XL
    Orthop Surg; 2017 Feb; 9(1):103-109. PubMed ID: 28276638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute anterior uveitis following zoledronic acid infusion for osteoporosis.
    Belliveau MJ; Almeida DR; Urton TE
    Can J Ophthalmol; 2012 Oct; 47(5):e22-3. PubMed ID: 23036555
    [No Abstract]   [Full Text] [Related]  

  • 18. Zoledronate-induced anterior uveitis, scleritis and optic neuritis: a case report.
    Wolpert LE; Watts AR
    N Z Med J; 2021 Jun; 134(1537):91-94. PubMed ID: 34239165
    [No Abstract]   [Full Text] [Related]  

  • 19. Two case reports of zoledronic acid-induced uveitis.
    Kennedy T; Sellar PW; Vaideanu-Collins D; Ng J
    Age Ageing; 2018 Sep; 47(5):754-755. PubMed ID: 29718071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial.
    Grey A; Bolland MJ; Horne A; Wattie D; House M; Gamble G; Reid IR
    Bone; 2012 Jun; 50(6):1389-93. PubMed ID: 22465268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.